rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTGCCAGTGCCCACAATGAGCAGTTCTTTGGGCCA	CASSVASAHNEQFF	In	VDJ	1	46	0.005161000785369685	0.006736965436438196	42	TCRBV09	TCRBV09-01					TCRBJ02			2	3	6	22	11	14	23	37	51	48	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05					Vb 1	CASSVASAHNEQFF+TCRBV09-01+TCRBJ02-X	TCRBV09-01		TCRBJ02	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGACTTAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	0.0026926960619320095		34	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	3	10	0	0	4	29	-1	40	37	44						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGACCTAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	0.0061707618085941884		34	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	4	9	0	2	2	29	37	42	39	44						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTACCCGGGACAGGCGAAAAACTGTTTTTTGGCAGT	CASSLPGTGEKLFF	In	VDJ	3	139	0.015595198025356222	0.020357352079671938	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	4	8	6	1	29	41	55	47	56													Vb 16	CASSLPGTGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGGACAGGGGGTAACTATGGCTACACCTTCGGTTCG	CASGTGGNYGYTF	In	VDJ	1	13	0.0014585437002131718	0.001903925014645577	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	1	1	2	0	24	31	-1	33	44														CASGTGGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGACTAGCGGGGGGGCCTTCCTTCTTCGGGCCA	CASSLGLAGGPSFF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	0	16	0	6	18	-1	48	34	54														CASSLGLAGGPSFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCGGAGCGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGAYSGANVLTF	In	VDJ	1	32	0.003590261415909346	0.0046865846514352666	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	6	6	0	5	2	18	30	39	35	41						01,02								CASSPGAYSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD02-01	TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGAGGACTAGCGGGGATTCACAATGAGCAGTTCTTCGGGCCA	CASRGLAGIHNEQFF	In	VDJ	1	16	0.001795130707954673	0.0023432923257176333	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	1	3	5	4	4	19	27	43	31	47														CASRGLAGIHNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAAGGGACTAGCCCACGAGCAGTACTTCGGGCCG	CASSLKGLAHEQYF	In	VDJ	1	16	0.001795130707954673	0.0023432923257176333	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	7	5	2	2	19	34	45	36	47						01,02								CASSLKGLAHEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTATCTTCGACAGCCCTAAGGGGCTACACCTTCGGTTCG	CASSLSSTALRGYTF	In	VDJ	1	33	0.003702457085156513	0.0048330404217926184	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	8	5	8	19	34	44	39	52														CASSLSSTALRGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCGACAGGACCACAGATACGCAGTATTTTGGCCCA	CASSPDRTTDTQYF	In	VDJ	1	41	0.0046000224391338496	0.006004686584651435	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	2	3	2	19	31	40	34	42														CASSPDRTTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGGGGACTAAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	15	0.001682935038707506		46	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	9	1	0	1	23	-1	46	39	47						01,02								X+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGGGGCGAACGGATTCAACTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	0.002019522046449007		50	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	3	6	0	1	1	14	26	37	44	38	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACGGGACAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSGRDRGNQPQHF	In	VDJ	1	21	0.0023561090541905083	0.0030755711775043936	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	3	2	3	0	26	39	-1	42	51													Vb 20	CAWSGRDRGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGCTGCGACCTGAGGCCAACGTCCTGACTTTCGGGGCC	CAWSVLRPEANVLTF	In	VDJ	1	21	0.0023561090541905083	0.0030755711775043936	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-06	01	0	2	7	6	5	4	26	40	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVLRPEANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02		TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGACCGCTTACTATGGCTACACCTTCGGTTCG	CAWSRTAYYGYTF	In	VDJ	1	47	0.005273196454616852	0.0068834212067955475	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	1	7	3	1	5	26	38	43	39	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSRTAYYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGCCGATAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDADNTGELFF	In	VDJ	1	17	0.00190732637720184	0.002489748096074985	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	2	8	2	4	1	23	40	46	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDADNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGTTGGGGGCTGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSLGWGLGNNEQFF	In	VDJ	1	18	0.002019522046449007	0.0026362038664323375	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	5	5	6	19	33	44	38	50													Vb 5.1	CASSLGWGLGNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATAACCGGGACAGGGTTTGACGAGCAGTACTTCGGGCCG	CASSITGTGFDEQYF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	6	4	25	37	52	43	56													Vb 3	CASSITGTGFDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAGAGGGGACGAGCAGTACTTCGGGCCG	CASSFRGDEQYF	In	VDJ	1	15	0.001682935038707506	0.0021968365553602814	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	5	2	5	3	0	25	39	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFRGDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTAAAAGCCGGGGCTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASLKAGASGQETQYF	In	VDJ	1	16	0.001795130707954673	0.0023432923257176333	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	4	5	1	13	0	25	34	-1	47	54						01,02							Vb 3	CASLKAGASGQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGCTCTACAATGAGCAGTTCTTCGGGCCA	CASSLLYNEQFF	In	VDJ	1	19	0.002131717715696174	0.0027826596367896894	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	5	10	0	3	2	1	25	37	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGTCAACGGCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSGQRPSTDTQYF	In	VDJ	1	21	0.0023561090541905083	0.0030755711775043936	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	5	9	0	0	7	2	25	37	47	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSGQRPSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGCTACCCGGCAGGGTCGGTGTTTGGCCAGCATTTTGGTGAT	CVSSYPAGSVFGQHF	In	VDJ	1	23	0.0025805003926848424	0.003368482718219098	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	12	8	11	25	36	49	44	60													Vb 3	CVSSYPAGSVFGQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCAAGACAGGGTTTTTTGGCTACACCTTCGGTTCG	CASSKTGFFGYTF	In	VDJ	1	33	0.003702457085156513	0.0048330404217926184	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	7	5	5	25	34	46	39	51													Vb 3	CASSKTGFFGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCTCGTGGGACGGGGACGGCAGGGAGGGAGCAGTACTTCGGGCCG	CASSFARGTGTAGREQYF	In	VDJ	1	34	0.00381465275440368	0.00497949619214997	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	7	22	0	25	39	-1	61	67													Vb 3	CASSFARGTGTAGREQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACATTACCGAAATTACTGTTTTTTGGCAGT	CASSLTLPKLLFF	In	VDJ	1	36	0.004039044092898014	0.005272407732864675	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	6	13	0	11	25	-1	43	40	54													Vb 3	CASSLTLPKLLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACAACCGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSLTTGTGNEKLFF	In	VDJ	1	37	0.004151239762145181	0.005418863503222027	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	3	5	6	0	25	40	-1	46	55													Vb 3	CASSLTTGTGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGTACGGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	59	0.006619544485582857		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	2	0	9	8	0	5	25	-1	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTGATAGCGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLIAGSSYEQYF	In	VDJ	2	81	0.009087849209020532	0.011862917398945518	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	3	0	4	2	25	37	49	41	51													Vb 3	CASSLIAGSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCTCTTGGACCGACACAGAGCAGCCCCAGCATTTTGGTGAT	CASSSSWTDTEQPQHF	In	VDJ	4	167	0.0187366767642769	0.024458113649677798	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	1	7	7	8	10	25	36	48	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSSWTDTEQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCGGTTTAAAGGGGGTAAGAAACACAGATACGCAGTATTTTGGCCCA	CATGLKGVRNTDTQYF	In	VDJ	4	193	0.021653764164703243	0.028265963678968952	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	1	2	1	7	25	40	47	41	54													Vb 3	CATGLKGVRNTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGTAAAGCGGTGGGACAGGGCTTTGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	160	0.01795130707954673		47	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	13	0	3	1	9	4	18	22	40	31	44														X+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGACTGGGGGGTCACACCTACAATGAGCAGTTCTTCGGGCCA	CASS*LGGHTYNEQFF	Stop	VDJ	1	16	0.001795130707954673		48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	2	5	5	23	35	46	40	51													Vb 12	CASS*LGGHTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACACGGGACAGGGGATGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	0.0014585437002131718		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	6	4	4	27	38	52	42	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCAGGGGGCAGTATGGGATGGCTACACCTTCGGTTCG	CASSSQGAVWDGYTF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	0	6	2	8	27	40	50	42	58			01,02										Vb 17	CASSSQGAVWDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACAAAAACGGCGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	15	0.001682935038707506		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	6	8	1	9	27	40	45	41	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCCGTTTCGTCGCCGGAAACACCATATATTTTGGAGAG	CASSIPRFVAGNTIYF	In	VDJ	1	18	0.002019522046449007	0.0026362038664323375	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	2	10	0	4	12	1	27	42	56	54	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPRFVAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGCGGCGGTACAGCCTCCTACGAGCAGTACTTCGGGCCG	CASSISGGTASYEQYF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	5	0	0	9	27	-1	47	42	56			01,02			01,02							Vb 17	CASSISGGTASYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGAGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGDSSGANVLTF	In	VDJ	1	22	0.0024683047234376754	0.003222026947861746	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	2	5	0	3	0	27	36	-1	39	44			01,02										Vb 17	CASGDSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCGACTAGCGTTAAGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	0.0026926960619320095		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	6	5	3	6	27	40	51	43	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCGTGGGACACTGAAGCTTTCTTTGGACAA	CASSIPWDTEAFF	In	VDJ	1	30	0.003365870077415012	0.004393673110720563	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	0	9	3	4	0	27	42	-1	46	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPWDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGGACGGTTGGAAACACCATATATTTTGGAGAG	CASSLGTVGNTIYF	In	VDJ	1	36	0.004039044092898014	0.005272407732864675	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	5	0	7	3	3	3	27	39	47	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGTVGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTCCGGGACAGGGGTGAACTACCATATATTTTGGAGAG	CASGPGQG*TTIYF	Stop	VDJ	1	47	0.005273196454616852		42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	0	2	10	5	6	27	36	51	41	57			01,02										Vb 17	CASGPGQG*TTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCACTAAAGGTCTGGAAACACCATATATTTTGGAGAG	CASSIGH*RSGNTIYF	Stop	VDJ	1	52	0.005834174800852687		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	3	9	1	3	4	27	43	50	46	54			01,02			01,02							Vb 17	CASSIGH*RSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCTAGCGGGGGGGCTGCCGGGGAGCTGTTTTTTGGAGAA	CASSIPSGGAAGELFF	In	VDJ	1	54	0.006058566139347021	0.007908611599297012	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	6	2	3	27	41	55	43	58			01,02										Vb 17	CASSIPSGGAAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACTAGCCTCCACCCAGAGACCCAGTACTTCGGGCCA	CASSPTSLHPETQYF	In	VDJ	2	73	0.008190283855043196	0.010691271236086701	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	7	4	2	8	27	39	48	41	56			01,02			01,02							Vb 17	CASSPTSLHPETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCAGTAGTATAACGGGCGGCACAGATACGCAGTATTTTGGCCCA	CVSSITGGTDTQYF	In	VDJ	2	79	0.008863457870526198	0.011570005858230814	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	2	8	0	1	2	1	27	42	48	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CVSSITGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSIGSSYEQYF	In	VDJ	2	101	0.011331762593963873	0.01479203280609256	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	5	0	1	0	27	43	-1	44	47			01,02										Vb 17	CASSIGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGGGGGACGCTTCGATGAGCAGTTCTTCGGGCCA	CASSDGGRFDEQFF	In	VDJ	3	120	0.013463480309660047	0.01757469244288225	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	2	8	0	8	23	-1	43	37	51													Vb 11	CASSDGGRFDEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAGAGGCGGACTAGCACAGATACGCAGTATTTTGGCCCA	CSERRTSTDTQYF	In	VDJ	1	25	0.0028048917311791766	0.003661394258933802	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	10	0	6	0	25	32	-1	38	43						01,02							Vb 4	CSERRTSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTTTACGGAACACTGAAGCTTTCTTTGGACAA	CSVEGLRNTEAFF	In	VDJ	1	27	0.0030292830696735107	0.003954305799648506	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	3	7	1	4	1	25	38	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGLRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCGGGACAGGGGGCACGAGAGCAGTACTTCGGGCCG	CSVPGQGAREQYF	In	VDJ	1	50	0.005609783462358353	0.007322788517867604	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	7	3	4	25	33	48	36	52													Vb 4	CSVPGQGAREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGAAGTTTTAACAGGGTAAGAGGTCCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	60	0.006731740154830024		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	2	5	10	25	38	49	43	59													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTAACAGGGGAAGAGACCCAGTACTTCGGGCCA	CSVLTGEETQYF	In	VDJ	2	81	0.009087849209020532	0.011862917398945518	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	3	3	0	25	34	-1	37	44													Vb 4	CSVLTGEETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGATGGGGCGATGGACTATGGCTACACCTTCGGTTCG	CASSYDGAMDYGYTF	In	VDJ	1	18	0.002019522046449007	0.0026362038664323375	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	7	0	3	6	5	28	40	51	46	56		TCRBV06-04,TCRBV06-08												CASSYDGAMDYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTCAGGAAGGGGGCCCGGTCCGACTGAAGCTTTCTTTGGACAA	CASSSGRGPGPTEAFF	In	VDJ	1	33	0.003702457085156513	0.0048330404217926184	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	0	5	2	8	19	35	44	37	52		TCRBV07-01,TCRBV07-05,TCRBV07-06												CASSSGRGPGPTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAAGGACGGGGCAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASKDGAGAYNEQFF	In	VDJ	1	41	0.0046000224391338496	0.006004686584651435	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	2	2	11	0	19	27	-1	38	44		TCRBV07-05,TCRBV07-06												CASKDGAGAYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCTTAGCGGTCTGAGACAGGGCGGGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	42	0.004712218108381017		52	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	2	3	4	7	5	22	39	53	46	58		TCRBV07-04,TCRBV07-05												X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCGCGAAAGAAATCGCACAAATTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	0.004936609446875351		55	TCRBV10	unresolved					TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGTCGGACAGGGGGCGCGTCCGGCTACACCTTCGGTTCG	CASSYGRTGGASGYTF	In	VDJ	2	71	0.007965892516548861	0.010398359695371997	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	0	8	4	6	23	38	53	42	59		TCRBV06-07,TCRBV06-08												CASSYGRTGGASGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGCTTAATGTTGGGACAGGCGAAGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	194	0.02176595983395041		49	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	4	7	5	5	19	34	47	39	52		TCRBV07-01,TCRBV07-05												X+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAACATGACAGGGGGCGGGACACCATATATTTTGGAGAG	CASSEHDRGRDTIYF	In	VDJ	1	13	0.0014585437002131718	0.001903925014645577	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	0	8	6	3	26	38	54	44	57		TCRBV12-03,TCRBV12-04												CASSEHDRGRDTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGGGTATATGGGAGAGACCCAGTACTTCGGGCCA	CASSLGGYMGETQYF	In	VDJ	1	13	0.0014585437002131718	0.001903925014645577	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	1	6	1	4	0	8	26	-1	47	42	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGYMGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGCGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	0.0015707393694603389		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	6	3	2	1	26	40	45	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAACCACGAACAGGGATTTTAAGCCCCAGCATTTTGGTGAT	CSARTTNRDFKPQHF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	8	10	6	26	35	51	45	57		TCRBV20-01,TCRBV20-or09_02												CSARTTNRDFKPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CTCCCWMYCAGACYTCTSTKTACTTCTGTGCCAGCAGTTTAGAACAGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEQGPYNEQFF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	2	4	1	26	39	50	43	51	TCRBV06,TCRBV27													CASSLEQGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTTTTTACCGGGACAGGCCCTACCGCCGGTGGTGGCTACACCTTCGGTTCG	CASSQVFTGTGPTAGGGYTF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	7	8	15	21	37	53	45	68	TCRBV01,TCRBV04													CASSQVFTGTGPTAGGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTCAACAGGGGTATTAATGAAAAACTGTTTTTTGGCAGT	CASSFNRGINEKLFF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	2	4	2	3	18	32	41	34	44	TCRBV07,TCRBV11													CASSFNRGINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCAAAACAGGGTCACAGCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	15	0.001682935038707506		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	2	7	6	26	34	47	41	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCACAGGGTAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTG*AYNEQFF	Stop	VDJ	1	15	0.001682935038707506		45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	2	3	4	24	36	45	39	49		TCRBV24-01,TCRBV24-or09_02												CASSSTG*AYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGGACAAAGAGGAGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	0.001795130707954673		43	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	0	6	5	0	11	22	-1	39	33	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGAGCTAAATGAAAAACTGTTTTTTGGCAGT	CASSLELNEKLFF	In	VDJ	1	17	0.00190732637720184	0.002489748096074985	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	4	9	5	6	0	26	38	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								CASSLELNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGGACAGGGGTTCTATGGCTACACCTTCGGTTCG	CATKGQGFYGYTF	In	VDJ	1	17	0.00190732637720184	0.002489748096074985	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	2	4	1	2	24	34	45	35	47		TCRBV24-01,TCRBV24-or09_02												CATKGQGFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTACAGGGTCCTCCTACGAGCAGTACTTCGGGCCG	CSASTGSSYEQYF	In	VDJ	1	18	0.002019522046449007	0.0026362038664323375	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	3	2	26	35	44	38	46		TCRBV20-01,TCRBV20-or09_02												CSASTGSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCAGCTTCTACATCTGCAGTGCCCAGAGCGGGACTAGCGGGGGGGGCGGGATGCGCACAGATACGCAGTATTTTGGCCCA	CSAQSGTSGGGGMRTDTQYF	In	VDJ	1	19	0.002131717715696174	0.0027826596367896894	60	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	0	1	7	9	15	23	46	30	55		TCRBV20-01,TCRBV20-or09_02												CSAQSGTSGGGGMRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCCTTCTCCGTGGAATTCACCCCTCCACTTTGGGAAC	CASTPSPWNSPLHF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	42	TCRBV24						TCRBJ01	TCRBJ01-06	01	11	0	10	7	15	0	24	31	-1	46	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPSPWNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTTTTGGATGATGAGACCCAGTACTTCGGGCCA	CASSFLDDETQYF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	39							TCRBJ02	TCRBJ02-05	01	3	1	8	5	3	4	42	56	62	59	66	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLDDETQYF+X+TCRBJ02-05			TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGTGGGAGCGTTAGAGACCCAGTACTTCGGGCCA	CSARVVGALETQYF	In	VDJ	1	21	0.0023561090541905083	0.0030755711775043936	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	2	4	4	4	26	39	48	43	52		TCRBV20-01,TCRBV20-or09_02												CSARVVGALETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCARCCARACAKCTWTGTACYTCTGTGCCAGCAGTCTACTCGACAGGGTTGGCGAGCAGTACTTCGGGCCG	CASSLLDRVGEQYF	In	VDJ	1	21	0.0023561090541905083	0.0030755711775043936	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	6	6	4	25	37	50	43	54	TCRBV22,TCRBV28													CASSLLDRVGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGTTGGGTGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	22	0.0024683047234376754		50	unresolved						TCRBJ02	TCRBJ02-06	01	5	0	9	5	3	12	18	30	36	33	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGCAGTGAGCTATATGGCTACACCTTCGGTTCG	CSASRSELYGYTF	In	VDJ	1	23	0.0025805003926848424	0.003368482718219098	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	4	5	5	3	7	26	37	43	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRSELYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTCTTGGGACCTACTTGGAAACACCATATATTTTGGAGAG	CASSSWDLLGNTIYF	In	VDJ	1	23	0.0025805003926848424	0.003368482718219098	45	unresolved						TCRBJ01	TCRBJ01-03	01	4	0	7	3	3	5	18	31	39	34	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWDLLGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTTACGGCGGGGGAAGGGGAGACCCAGTACTTCGGGCCA	CASSFTAGEGETQYF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	5	4	5	26	40	51	44	56	TCRBV12,TCRBV21													CASSFTAGEGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGACAGGGTTTATGGCTACACCTTCGGTTCG	CASSPRDRVYGYTF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	5	3	2	26	39	51	42	53		TCRBV03-01,TCRBV03-02												CASSPRDRVYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAAGGGCAGGGTCCGACTCTGGGGCCAACGTCCTAACTTTCGGGGCC	CASSLRAGSDSGANVLTF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	4	3	19	4	24	19	34	43	38	67	TCRBV07,TCRBV11													CASSLRAGSDSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACGTTGGGACAGGGTTTGAATGAGCAGTTCTTCGGGCCA	CSARTLGQGLNEQFF	In	VDJ	1	25	0.0028048917311791766	0.003661394258933802	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	7	6	4	26	37	52	43	56		TCRBV20-01,TCRBV20-or09_02												CSARTLGQGLNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTAGTCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFSQNTGELFF	In	VDJ	1	26	0.0029170874004263436	0.003807850029291154	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	8	1	2	3	26	38	43	40	46		TCRBV03-01,TCRBV03-02				01,02								CASSFSQNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGGGAYTCAGCWGTGTAYTTYTGTGCCAGCAGCGTATGGGACTAGCGGGGGGGCCAGTCTCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	0.0029170874004263436		58	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	4	4	10	16	28	48	32	58	TCRBV12,TCRBV16													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACTTATTCTAGCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASTYSSGGYNEQFF	In	VDJ	1	27	0.0030292830696735107	0.003954305799648506	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	4	1	4	9	0	24	31	-1	40	51		TCRBV24-01,TCRBV24-or09_02												CASTYSSGGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGAATGTGCGGCTAAAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CARMCG*SRQSRANVLTF	Stop	VDJ	1	27	0.0030292830696735107		54							TCRBJ02	TCRBJ02-06	01	9	2	6	5	17	5	18	26	47	43	52	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARMCG*SRQSRANVLTF+X+TCRBJ02-06			TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GRGGGACTCAGCYGTGTATCTCTRYGCCAGCAGCCAGCTAACAGAGAACACTGAAGCTTTCTTTGGACAA	XASSQLTENTEAFF	In	VDJ	1	27	0.0030292830696735107	0.003954305799648506	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	1	4	1	22	36	44	40	45	TCRBV04,TCRBV07,TCRBV17													XASSQLTENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGGTACCCTGGGTAGGACGGCTCCTACGAGCAGTACTTCGGGCCG	CASRYPG*DGSYEQYF	Stop	VDJ	1	27	0.0030292830696735107		48	unresolved						TCRBJ02	TCRBJ02-07	01	6	1	7	0	12	2	24	35	51	47	53	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYPG*DGSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GASWCGSMSSYRTRTRYCTGTGTCAGAAGCTTAAGAGGGGCTCGGGGCGAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	0.0031414787389206777		44	unresolved						TCRBJ02	TCRBJ02-05	01	14	5	2	6	12	10	18	21	38	33	48	TCRBV07,TCRBV15			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTAGGACTAATAATGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	0.0031414787389206777		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	9	4	2	20	23	34	42	36	62	TCRBV09,TCRBV21					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACAAACAGGGGGTCGCGGCTACACCTTCGGTTCG	CASRQTGGRGYTF	In	VDJ	1	30	0.003365870077415012	0.004393673110720563	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	1	8	4	4	24	35	47	39	51		TCRBV24-01,TCRBV24-or09_02												CASRQTGGRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAGGTTACGGGCAGGGGCAGCCCCAGCATTTTGGTGAT	CASSLGYGQGQPQHF	In	VDJ	1	30	0.003365870077415012	0.004393673110720563	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	7	8	0	18	34	-1	42	48	TCRBV11,TCRBV23													CASSLGYGQGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGACTCGGCYGTGTATSTCTGTGCAAGTCGCTTAGGGAGGACAGGGAATTCACCCCTCCACTTTGGGAAC	CASRLGRTGNSPLHF	In	VDJ	1	32	0.003590261415909346	0.0046865846514352666	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	1	3	7	3	0	18	34	-1	37	45	TCRBV07,TCRBV12													CASRLGRTGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCCCCTATACAGGGTACTGAAGCTTTCTTTGGACAA	CNAPIQGTEAFF	In	VDJ	1	33	0.003702457085156513	0.0048330404217926184	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	6	1	26	34	46	40	47		TCRBV20-01,TCRBV20-or09_02												CNAPIQGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCTCTGGGGGTGAAGCTTTCTTTGGACAA	CSASSGGEAFF	In	VDJ	1	34	0.00381465275440368	0.00497949619214997	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	6	1	7	6	0	26	35	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSGGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAATTGGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSEIGGGTDTQYF	In	VDJ	1	35	0.003926848423650847	0.005125951962507323	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	3	1	8	0	23	34	-1	42	48	TCRBV09,TCRBV21													CASSEIGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAGTCACGTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	0.004151239762145181		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	15	0	26	38	-1	53	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGGCGGGACAGGGATAATTCACCCCTCCACTTTGGGAAC	CASRRDRDNSPLHF	In	VDJ	1	40	0.0044878267698866825	0.005858230814294083	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	5	2	0	26	37	-1	39	48	TCRBV06,TCRBV10													CASRRDRDNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGTAGCAGGGGGTTTCACTGAAGCTTTCTTTGGACAA	CASSVAGGFTEAFF	In	VDJ	1	42	0.004712218108381017	0.006151142355008787	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	4	0	3	26	-1	49	43	52		TCRBV12-03,TCRBV12-04												CASSVAGGFTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCCCATAGCACAGATACGCAGTATTTTGGCCCA	CSARDPHSTDTQYF	In	VDJ	1	43	0.004824413777628184	0.006297598125366139	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	6	0	4	1	26	40	46	44	47		TCRBV20-01,TCRBV20-or09_02												CSARDPHSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGTGTAGAGACCCAGTACTTCGGGCCA	CSASGVETQYF	In	VDJ	1	43	0.004824413777628184	0.006297598125366139	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	5	4	0	3	26	-1	40	37	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTAGGGTCCCCGGGACTAGGGGTATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	43	0.004824413777628184		53	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	8	3	11	6	26	36	55	47	61		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGCGATCGGCTATTCACAGATACGCAGTATTTTGGCCCA	CSARRDRLFTDTQYF	In	VDJ	1	44	0.004936609446875351	0.006444053895723492	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	9	0	2	7	4	26	38	48	45	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDRLFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGGTTCAGTCTCTGGAAACACCATATATTTTGGAGAG	CSASGGSVSGNTIYF	In	VDJ	1	45	0.005048805116122518	0.006590509666080844	45	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	6	1	0	1	6	26	37	43	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGSVSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCCTCAACTACAATGAGCAGTTCTTCGGGCCA	CSPLNYNEQFF	In	VDJ	1	46	0.005161000785369685	0.006736965436438196	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	8	4	6	3	5	1	26	32	39	37	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSPLNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTTACATCTCCCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	48	0.005385392123864019		47	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	2	3	6	26	38	44	41	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACTGTCTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	48	0.005385392123864019		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	2	10	5	0	18	26	-1	43	39	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCACTTCTGGTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASHFWLSSYNEQFF	In	VDJ	1	50	0.005609783462358353	0.007322788517867604	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	10	0	2	10	26	37	42	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSASHFWLSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGAGCGGGGGGGCCAACGAGCAGTACTTCGGGCCG	CSALSGGANEQYF	In	VDJ	1	50	0.005609783462358353	0.007322788517867604	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	5	3	3	26	35	48	38	51		TCRBV20-01,TCRBV20-or09_02												CSALSGGANEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGAGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CASSVEGLADNEQFF	In	VDJ	1	50	0.005609783462358353	0.007322788517867604	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	5	6	0	22	33	-1	39	50		TCRBV12-03,TCRBV12-04				01,02								CASSVEGLADNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCCGCCTGATAACACCCCTCCACTTTGGGAAC	CASSRLITPLHF	In	VDJ	1	56	0.0062829574778413555	0.008201523140011716	36	unresolved						TCRBJ01	TCRBJ01-06	01	4	2	8	11	4	3	26	39	45	43	48	TCRBV03,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLITPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGCGGTCGGGACAGATACGCAGTATTTTGGCCCA	CATRAVGTDTQYF	In	VDJ	1	56	0.0062829574778413555	0.008201523140011716	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	7	5	3	1	5	24	35	40	36	45		TCRBV24-01,TCRBV24-or09_02				01,02								CATRAVGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGGAGCGGGGGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASRERGGGTDTQYF	In	VDJ	1	61	0.006843935824077191	0.008933801991798477	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	1	2	2	23	34	46	36	48	TCRBV02,TCRBV21													CASRERGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGAGCGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CSARGSGGGEKLFF	In	VDJ	1	62	0.006956131493324358	0.00908025776215583	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	6	2	7	4	3	26	37	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSARGSGGGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGACCGCTAGCGGGGATTTACAATGAGCAGTTCTTCGGGCCA	CASRPLAGIYNEQFF	In	VDJ	1	63	0.007068327162571525	0.00922671353251318	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	4	4	3	18	29	42	33	45	TCRBV05,TCRBV11													CASRPLAGIYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTAGCGGGGCTTGGGGATACGCAGTATTTTGGCCCA	CATSLAGLGDTQYF	In	VDJ	1	65	0.007292718501065859	0.009519625073227886	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	6	1	6	24	35	45	36	51		TCRBV24-01,TCRBV24-or09_02												CATSLAGLGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGGCTAGCGAATCATTAACTTGCCTACGAGCAGTACTTCGGGCCG	CATSDLRLANH*LAYEQYF	Stop	VDJ	1	65	0.007292718501065859		57	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	6	2	3	13	24	42	51	45	64		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDLRLANH*LAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGGAGTCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	66	0.007404914170313026		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	7	2	4	0	14	26	-1	46	39	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCGACGGTACACTGAAGCTTTCTTTGGACAA	CASSLRRYTEAFF	In	VDJ	1	67	0.007517109839560193	0.00981253661394259	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	2	7	3	3	3	26	39	45	42	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACGACTAGGACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	68	0.00762930550880736		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	8	2	3	4	26	37	46	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGTGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSQAGGPGELFF	In	VDJ	1	69	0.007741501178054527	0.010105448154657293	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	8	0	6	5	0	26	42	-1	47	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGGPGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGACTCAATCTCAGAGATACGCAGTATTTTGGCCCA	CSGLNLRDTQYF	In	VDJ	2	79	0.008863457870526198	0.011570005858230814	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	2	10	5	0	9	26	-1	37	33	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSGLNLRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTCATTAGCGGCCGCACAGATACGCAGTATTTTGGCCCA	CASSFISGRTDTQYF	In	VDJ	2	88	0.009873218893750701	0.012888107791446984	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	5	1	6	2	24	35	47	41	49	TCRBV12,TCRBV21					01,02								CASSFISGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAACCCCGGGACATTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	99	0.01110737125546954		46	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	0	8	1	26	37	51	45	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGGGGCCCTGCCGCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	122	0.013687871648154382		43				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	2	0	8	18	-1	35	30	43	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCGGGACAGCCTCCTACGAGCAGTACTTCGGGCCG	CASSQVGTASYEQYF	In	VDJ	6	280	0.03141478738920678	0.041007615700058585	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	0	2	1	23	39	48	41	49	TCRBV01,TCRBV04													CASSQVGTASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTTGGATGATGAGACCCAGTACTTCGGGCCA	CASSFLDDETQYF	In	VDJ	6	294	0.032985526758667116	0.04305799648506151	39	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	1	8	5	5	4	24	36	44	41	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLDDETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACCCGCCAGCGGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSYPPAGGNEQFF	In	VDJ	1	23	0.0025805003926848424	0.003368482718219098	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	7	8	0	28	40	-1	48	58			01,02											CASSYPPAGGNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCGGCTAGCGGGGGCCCCCAATGAGCAGTTTTTCGGGCCA	CASRLAGAPNEQFF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02			8	4	2	19	3	17	26	35	48	38	65								TCRBJ02-01,TCRBJ02-05						CASRLAGAPNEQFF+TCRBV06-07+TCRBJ02-X	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAATACCCAGGGGGGCATGTATGGCTACACCTTCGGTTCG	CASNTQGGMYGYTF	In	VDJ	1	31	0.003478065746662179	0.004540128881077915	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	5	5	5	26	36	48	41	53														CASNTQGGMYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTTATTCAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSFIQGSYEQYF	In	VDJ	1	13	0.0014585437002131718	0.001903925014645577	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	1	4	0	19	33	-1	37	43														CASSFIQGSYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GGACTCAGCCATGTATCGCTGTGCCAGAACCGGGACAGGGGGCCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	0.0043756311006395154		40	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	0	6	4	2	19	27	43	31	45														X+TCRBV07-07+TCRBJ01-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGACCATGGCGAAAGCGAACAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	29	0.003253674408167845		53	TCRBV22	TCRBV22-01	01				TCRBJ02	TCRBJ02-06	01	5	3	5	5	16	2	25	36	56	52	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01		TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACCTACTCGGCGAGCAGTACTTCGGGCCG	CASSHLLGEQYF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	36	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	10	6	3	3	23	37	43	40	46						01,02							Vb 7.1	CASSHLLGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGCCGACAGGGCCAGTGGCTACACCTTCGGTTCG	YASSQADRASGYTF	In	VDJ	1	33	0.003702457085156513	0.0048330404217926184	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	7	2	4	22	38	47	40	51													Vb 7.1	YASSQADRASGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTGGAATTCGGGCGCAATGAGCAGTTCTTCGGGCCA	CASSLEFGRNEQFF	In	VDJ	1	34	0.00381465275440368	0.00497949619214997	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	5	8	0	6	9	1	18	30	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEFGRNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTAGAATAACAGGGGACGGCTACACCTTCGGTTCG	CATSSRITGDGYTF	In	VDJ	1	55	0.0061707618085941884	0.008055067369654365	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	2	8	7	2	18	32	46	39	48														CATSSRITGDGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAAGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSKGANTGELFF	In	VDJ	1	66	0.007404914170313026	0.009666080843585237	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	4	5	4	0	1	2	18	31	35	32	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSKGANTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGTTAGGAAGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLGRTNTGELFF	In	VDJ	1	13	0.0014585437002131718	0.001903925014645577	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	1	8	0	6	4	18	30	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGRTNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAGTAGTGAGACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSEVVRRQSRANVLTF	In	VDJ	1	15	0.001682935038707506	0.0021968365553602814	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	13	5	18	30	47	43	52														CASSEVVRRQSRANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCGAGACAGGGCAACACTGAAGCTTTCTTTGGACAA	CASSPRQGNTEAFF	In	VDJ	1	16	0.001795130707954673	0.0023432923257176333	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	2	5	1	18	29	41	34	42														CASSPRQGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTAGTAAGTCGAAAGACCTAYGGCTACACCTTCGGTTCG		Out	VDJ	1	16	0.001795130707954673		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	14	0	18	29	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACGGGGCAGGGGTTAAAGACCCAGTACTTCGGGCCA	CASSSTGQGLKTQYF	In	VDJ	1	19	0.002131717715696174	0.0027826596367896894	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	6	8	4	18	31	45	39	49														CASSSTGQGLKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGTGATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGDYSNQPQHF	In	VDJ	1	28	0.0031414787389206777	0.004100761570005858	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	0	10	0	1	6	18	32	35	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGDYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCTTGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSLLGGYTEAFF	In	VDJ	1	47	0.005273196454616852	0.0068834212067955475	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	3	6	1	18	30	42	36	43														CASSLLGGYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATAATACTGAGGGCTACGAGCAGTACTTCGGGCCG	CASSHNTEGYEQYF	In	VDJ	2	108	0.012117132278694043	0.015817223198594025	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	0	3	9	0	18	30	-1	39	44														CASSHNTEGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCTGGCAGGGCCAACAATGAGCAGTTCTTCGGGCCA	CASSSPGRANNEQFF	In	VDJ	3	143	0.01604398070234489	0.02094317516110135	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	7	3	18	31	43	38	46														CASSSPGRANNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATGCTACGGGAGACTACGAGCAGTACTTCGGGCCG	CASSNATGDYEQYF	In	VDJ	3	155	0.017390328733310895	0.02270064440538957	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	3	7	1	18	30	43	37	44														CASSNATGDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGAGATACAGGGGGCCCTTGGCTACACCTTCGGTTCG	CASSREIQGALGYTF	In	VDJ	7	329	0.036912375182317964	0.04818394844756883	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	7	8	3	18	30	47	38	50														CASSREIQGALGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATTACCCCCGAGGGGAGCAGTTCTTCGGGCCA	CASNYPRGEQFF	In	VDJ	1	15	0.001682935038707506	0.0021968365553602814	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	11	0	10	14	0	26	31	-1	45	50														CASNYPRGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCCGAGTTAGGACCGCTAGTCAGCCCCAGCATTTTGGTGAT	CASGPRVRTASQPQHF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	48	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	5	1	7	6	10	6	26	38	52	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPRVRTASQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACGGGACAGTAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	0.007404914170313026		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	5	7	2	5	26	43	52	45	57														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTTCCCCCACAGATACGCAGTATTTTGGCCCA	CASGFSPTDTQYF	In	VJ	6	286	0.03208796140468978	0.0418863503222027	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	3	0	0	2	0	6	26	-1	40	-1	46														CASGFSPTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATGCTCGGCGGAATTGAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	0.0015707393694603389		44	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	5	6	6	20	34	44	40	50						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGACCCGGGTCGGCGGTATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	0.0023561090541905083		46	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	5	11	3	20	33	48	44	51						01,02								X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCGACCGGGACCCCTAAAAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	0.0015707393694603389		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	0	7	4	8	9	23	33	46	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGCGGGGGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSLAGGPNEQFF	In	VDJ	1	16	0.001795130707954673	0.0023432923257176333	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	6	1	2	23	34	47	35	49														CASSLAGGPNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACACGCGACGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDTRRSNQPQHF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	1	2	8	23	34	42	36	50														CASSRDTRRSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGACGGAGACACAGGGAGCGTGTTTGATCAGCCCCAGCATTTTGGTGAT	CASSADGDTGSVFDQPQHF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	5	12	10	23	35	53	47	63														CASSADGDTGSVFDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCCTACAAGCAGGGCTCCACATACGCAGTATTTTGGCCCA	CASNPTSRAPHTQYF	In	VDJ	1	23	0.0025805003926848424	0.003368482718219098	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	7	10	6	23	33	48	43	54														CASNPTSRAPHTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCAGCGTCCGGTCTAGCGGGGGGAACTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASASGLAGGTANTGELFF	In	VDJ	1	25	0.0028048917311791766	0.003661394258933802	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	11	4	1	0	12	5	23	29	52	41	57														CASASGLAGGTANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGCGGTGGACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSSGGRANTEAFF	In	VDJ	1	27	0.0030292830696735107	0.003954305799648506	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	6	5	1	1	9	23	34	40	35	49						01,02								CASSSGGRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGACAGACTTATCATACCTTCGGTTCG	CASSGGQTYHTF	In	VDJ	1	28	0.0031414787389206777	0.004100761570005858	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	14	2	9	23	35	44	37	53														CASSGGQTYHTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCACAGGGACGGTGGGCGGCTACACCTTCGGTTCG	CASSYSTGTVGGYTF	In	VDJ	1	29	0.003253674408167845	0.00424721734036321	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	8	1	9	23	40	47	41	56														CASSYSTGTVGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGAGGGACAGGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	0.003253674408167845		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	4	3	1	23	39	53	42	54														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGGGGATACTTGGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	41	0.0046000224391338496		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	3	0	8	23	-1	46	40	54														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCTAGCGGTACGACCGGGGAGCTGTTTTTTGGAGAA	CASRASGTTGELFF	In	VDJ	1	42	0.004712218108381017	0.006151142355008787	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	5	5	2	4	23	34	43	36	47						01,02								CASRASGTTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTAGTTACTCCACAGGGACGGTGGGCGGCTACACTTTCGGTTCG	CASSYSTGTVGGYTF	In	VDJ	1	45	0.005048805116122518	0.006590509666080844	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	17	1	18	23	40	47	41	65														CASSYSTGTVGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGTCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSWSATNEKLFF	In	VDJ	1	50	0.005609783462358353	0.007322788517867604	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	5	0	3	0	23	36	-1	39	42														CASSWSATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGACAGGGTGGAAACATTCAGTACTTAGGCGCC	CASSRQGGNIQYL	In	VDJ	1	53	0.005946370470099854	0.007762155828939661	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	3	22	1	19	23	35	43	36	62														CASSRQGGNIQYL+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTAACACTGAAGCTTTCTTTGGACAA	CASSYGNTEAFF	In	VDJ	1	59	0.006619544485582857	0.008640890451083773	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	10	2	0	1	23	-1	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGGTAAACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	112	0.012565914955682711		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	5	3	3	23	35	48	38	51														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTACGGGGGCAGCTATAATTCACCCCTCCACTTTGGGAAC	CASTYGGSYNSPLHF	In	VDJ	3	126	0.01413665432514305	0.01845342706502636	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	7	6	0	3	5	2	23	33	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTYGGSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCTCCAGGGGGGGCATCAAATACGCAGTATTTTGGCCCA	CASTPPGGASNTQYF	In	VDJ	3	145	0.016268372040839224	0.02123608670181605	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	4	1	7	6	8	23	33	46	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPPGGASNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGACGGATTAGCACAGATACGCAGTATTTTGGCCCA	CASSSGRISTDTQYF	In	VDJ	1	14	0.0015707393694603389	0.002050380785002929	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	5	1	7	0	3	5	24	36	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSGRISTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGCCTCACGCGGGAGAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	0.0022439133849433412		55	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	7	2	0	8	2	24	40	55	48	57													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAGGCCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGRNTGELFF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	10	1	1	0	3	24	-1	44	39	47													Vb 18	CASSPGGRNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTGGGAAGGGGTGTCTAACTATGGCTACACCTTCGGTTCG	CASSPWEGVSNYGYTF	In	VDJ	1	20	0.0022439133849433412	0.0029291154071470417	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	2	0	6	3	24	38	49	44	52													Vb 18	CASSPWEGVSNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACGGTCTAGCGGGGGGGACGAGCAGTACTTCGGGCCG	CASSQRSSGGDEQYF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	5	6	0	24	37	-1	43	55													Vb 18	CASSQRSSGGDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCATGGGACAGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSWDRSTGELFF	In	VDJ	1	24	0.0026926960619320095	0.0035149384885764497	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	4	4	2	24	36	48	40	50													Vb 18	CASSSWDRSTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAAGACGGATTAGCACAGATACGCAGTATTTTGGCCCA	CASSSRRISTDTQYF	In	VDJ	1	27	0.0030292830696735107	0.003954305799648506	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	5	1	8	0	7	2	24	36	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSRRISTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAACGTCGGGGCAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	32	0.003590261415909346		47	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	7	0	1	6	2	24	39	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCTGGGGGGTACTTAGAGACCCAGTACTTCGGGCCA	CASSSGGYLETQYF	In	VDJ	2	83	0.009312240547514866	0.012155828939660223	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	1	4	3	5	24	36	45	39	50													Vb 18	CASSSGGYLETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	9883A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				246	188	50	6	0	188	141	40	7	0	8913	6828	1836	249	0	0.0796981752	6.57054234	0.0702177584	7.02412271				5941	0.0323274843	0.0481839478	0.0369123742	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:55	Age (Range):65+ Years (Old Age),Age:73 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1840,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 744,type of chemo:carbo/taxol	0.764227621446312	MSKCC- Snyder- P01-02		192.0	
